Compare CTMX & BHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTMX | BHB |
|---|---|---|
| Founded | 2008 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.2M | 498.0M |
| IPO Year | 2015 | 1997 |
| Metric | CTMX | BHB |
|---|---|---|
| Price | $3.89 | $31.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $6.50 | ★ $34.50 |
| AVG Volume (30 Days) | ★ 2.4M | 76.3K |
| Earning Date | 11-06-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 4.10% |
| EPS Growth | ★ 50.22 | N/A |
| EPS | 0.24 | ★ 2.31 |
| Revenue | $113,631,000.00 | ★ $152,613,000.00 |
| Revenue This Year | N/A | $19.19 |
| Revenue Next Year | N/A | $12.86 |
| P/E Ratio | $16.28 | ★ $13.54 |
| Revenue Growth | N/A | ★ 3.15 |
| 52 Week Low | $0.40 | $26.43 |
| 52 Week High | $4.62 | $36.00 |
| Indicator | CTMX | BHB |
|---|---|---|
| Relative Strength Index (RSI) | 51.40 | 60.76 |
| Support Level | $3.66 | $30.66 |
| Resistance Level | $4.20 | $31.47 |
| Average True Range (ATR) | 0.24 | 0.76 |
| MACD | -0.04 | 0.17 |
| Stochastic Oscillator | 43.84 | 89.18 |
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
Bar Harbor Bankshares Inc is a bank holding company along with its subsidiaries that offers a full range of financial services products, brokerage services through third-party brokerage arrangements and also trust and investment management services to individuals, businesses, non-profit organizations, and municipalities. The company has following reportable segments such as Commercial construction, Commercial real estate owner occupied and non-owner occupied, Tax Exempt, Commercial and industrial loans, Residential real estate, Home equity and Consumer other. Its products and services consist of checking, deposits, cards, mobile banking, online services, loans, merchant services, trust, and fiduciary services, investment planning, education funding, individual retirement planning..